188 related articles for article (PubMed ID: 17900864)
21. Phosphatidylinositol-3-kinase-gamma is integral to homing functions of progenitor cells.
Chavakis E; Carmona G; Urbich C; Göttig S; Henschler R; Penninger JM; Zeiher AM; Chavakis T; Dimmeler S
Circ Res; 2008 Apr; 102(8):942-9. PubMed ID: 18323525
[TBL] [Abstract][Full Text] [Related]
22. AEG-1 promotes anoikis resistance and orientation chemotaxis in hepatocellular carcinoma cells.
Zhou Z; Deng H; Yan W; Luo M; Tu W; Xia Y; He J; Han P; Fu Y; Tian D
PLoS One; 2014; 9(6):e100372. PubMed ID: 24941119
[TBL] [Abstract][Full Text] [Related]
23. Involvement of phosphoinositide 3-kinase gamma, Rac, and PAK signaling in chemokine-induced macrophage migration.
Weiss-Haljiti C; Pasquali C; Ji H; Gillieron C; Chabert C; Curchod ML; Hirsch E; Ridley AJ; Hooft van Huijsduijnen R; Camps M; Rommel C
J Biol Chem; 2004 Oct; 279(41):43273-84. PubMed ID: 15292195
[TBL] [Abstract][Full Text] [Related]
24. Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt.
Cao Z; Liu L; Packwood W; Merkel M; Hurn PD; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H302-10. PubMed ID: 17982014
[TBL] [Abstract][Full Text] [Related]
25. Neutrophils lacking phosphoinositide 3-kinase gamma show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis.
Hannigan M; Zhan L; Li Z; Ai Y; Wu D; Huang CK
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3603-8. PubMed ID: 11904423
[TBL] [Abstract][Full Text] [Related]
26. A pharmacological model reveals biased dependency on PI3K isoforms for tumor cell growth.
Wang X; Li JP; Yang Y; Ding J; Meng LH
Acta Pharmacol Sin; 2013 Sep; 34(9):1201-7. PubMed ID: 23892273
[TBL] [Abstract][Full Text] [Related]
27. Regulation of CD38 expression in human airway smooth muscle cells: role of class I phosphatidylinositol 3 kinases.
Jude JA; Tirumurugaan KG; Kang BN; Panettieri RA; Walseth TF; Kannan MS
Am J Respir Cell Mol Biol; 2012 Oct; 47(4):427-35. PubMed ID: 22556157
[TBL] [Abstract][Full Text] [Related]
28. Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases.
Curnock AP; Logan MK; Ward SG
Immunology; 2002 Feb; 105(2):125-36. PubMed ID: 11872087
[TBL] [Abstract][Full Text] [Related]
29. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
[TBL] [Abstract][Full Text] [Related]
30. Biophysical and Structural Characterization of Novel RAS-Binding Domains (RBDs) of PI3Kα and PI3Kγ.
Martinez NG; Thieker DF; Carey LM; Rasquinha JA; Kistler SK; Kuhlman BA; Campbell SL
J Mol Biol; 2021 Apr; 433(8):166838. PubMed ID: 33539876
[TBL] [Abstract][Full Text] [Related]
31. The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes.
Sotsios Y; Whittaker GC; Westwick J; Ward SG
J Immunol; 1999 Dec; 163(11):5954-63. PubMed ID: 10570282
[TBL] [Abstract][Full Text] [Related]
32. Targeting the phosphoinositide 3-kinase p110-α isoform impairs cell proliferation, survival, and tumor growth in small cell lung cancer.
Wojtalla A; Fischer B; Kotelevets N; Mauri FA; Sobek J; Rehrauer H; Wotzkow C; Tschan MP; Seckl MJ; Zangemeister-Wittke U; Arcaro A
Clin Cancer Res; 2013 Jan; 19(1):96-105. PubMed ID: 23172887
[TBL] [Abstract][Full Text] [Related]
33. PI3Kgamma-dependent signaling in mouse olfactory receptor neurons.
Brunert D; Klasen K; Corey EA; Ache BW
Chem Senses; 2010 May; 35(4):301-8. PubMed ID: 20190008
[TBL] [Abstract][Full Text] [Related]
34. Recent patents of gene sequences relative to the phosphatidylinositol 3-kinase/Akt pathway and their relevance to drug discovery.
Doepfner KT; Boller D; De Laurentiis A; Guerreiro AS; Marinov M; Arcaro A
Recent Pat DNA Gene Seq; 2007; 1(1):9-23. PubMed ID: 19075915
[TBL] [Abstract][Full Text] [Related]
35. PI3K class IB pathway.
Andrews S; Stephens LR; Hawkins PT
Sci STKE; 2007 Oct; 2007(407):cm2. PubMed ID: 17925573
[TBL] [Abstract][Full Text] [Related]
36. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.
Barberis L; Hirsch E
Thromb Haemost; 2008 Feb; 99(2):279-85. PubMed ID: 18278175
[TBL] [Abstract][Full Text] [Related]
37. Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages.
Papakonstanti EA; Zwaenepoel O; Bilancio A; Burns E; Nock GE; Houseman B; Shokat K; Ridley AJ; Vanhaesebroeck B
J Cell Sci; 2008 Dec; 121(Pt 24):4124-33. PubMed ID: 19033389
[TBL] [Abstract][Full Text] [Related]
38. Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration.
Ticchioni M; Charvet C; Noraz N; Lamy L; Steinberg M; Bernard A; Deckert M
Blood; 2002 May; 99(9):3111-8. PubMed ID: 11964272
[TBL] [Abstract][Full Text] [Related]
39. The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3).
Caccuri F; Bugatti A; Corbellini S; Roversi S; Zani A; Mazzuca P; Marsico S; Caruso A; Giagulli C
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653015
[TBL] [Abstract][Full Text] [Related]
40. Resistance to thromboembolism in PI3Kgamma-deficient mice.
Hirsch E; Bosco O; Tropel P; Laffargue M; Calvez R; Altruda F; Wymann M; Montrucchio G
FASEB J; 2001 Sep; 15(11):2019-21. PubMed ID: 11511514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
